Malykhina AP, Lei Q, Chang S, Pan XQ, Villamor AN, Smith AL, Seftel AD. Bladder outlet obstruction triggers neural plasticity in sensory pathways and contributes to impaired sensitivity in erectile dysfunction. Am J Physiol Regul Integr Comp Physiol 304: R837-R845, 2013. First published March 27, 2013 doi:10.1152/ajpregu.00558.2012.-Lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) are common problems in aging males worldwide. The objective of this work was to evaluate the effects of bladder neck nerve damage induced by partial bladder outlet obstruction (PBOO) on sensory innervation of the corpus cavernosum (CC) and CC smooth muscle (CCSM) using a rat model of PBOO induced by a partial ligation of the bladder neck. Retrograde labeling technique was used to label dorsal root ganglion (DRG) neurons that innervate the urinary bladder and CC. Contractility and relaxation of the CCSM was studied in vitro, and expression of nitric oxide synthase (NOS) was evaluated by Western blotting. Concentration of the sensory neuropeptides substance P (SP) and calcitonin gene-related peptide was measured by ELISA. Partial obstruction of the bladder neck caused a significant hypertrophy of the urinary bladders (2.5-fold increase at 2 wk). Analysis of L6-S2 DRG sections determined that sensory ganglia received input from both the urinary bladder and CC with 5-7% of all neurons double labeled from both organs. The contractile responses of CC muscle strips to KCl and phenylephrine were decreased after PBOO, followed by a reduced relaxation response to nitroprusside. A significant decrease in neuronal NOS expression, but not in endothelial NOS or protein kinase G (PKG-1), was detected in the CCSM of the obstructed animals. Additionally, PBOO caused some impairment to sensory nerves as evidenced by a fivefold downregulation of SP in the CC (P Յ 0.001). Our results provide evidence that PBOO leads to the impairment of bladder neck afferent innervation followed by a decrease in CCSM relaxation, downregulation of nNOS expression, and reduced content of sensory neuropeptides in the CC smooth muscle. These results suggest that nerve damage in PBOO may contribute to LUTS-ED comorbidity and trigger secondary changes in the contraction/relaxation mechanisms of CCSM. sensory neurons; corpus cavernosum; smooth muscle contractility; afferent innervation LOWER URINARY TRACT SYMPTOMS (LUTS) associated with benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) are common problems in aging males worldwide (5, 50, 53). Large-scale epidemiological studies established the link between LUTS and ED with more severe LUTS associated with a greater prevalence of ED (6, 24, 35, 49, 56) . Despite the strong epidemiological evidence of correlation between the LUTS and ED, the underlying biological mechanisms of LUTS-ED comorbidity are not fully understood. Some of the suggested pathophysiological pathways include vascular changes, altered tone, and contractility of the corpus cavernosum (CC) smooth muscle (CCSM), nitric oxide (NO), and phosphodiesterasedependent dysfunctions and a decrease in circulating sex hormones (36, 42, 50, 59) .
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Physiological transition between flaccid and erect states is supported by coordinated activity of the penile blood vessels and smooth muscle, which occurs in parallel with a complex interaction between afferent and efferent nerves (1, 15) . However, neural mechanisms of LUTS-ED comorbidity are less studied compared with vascular and muscle components. Epidemiological studies suggested a link between BPH and increased autonomic tone (17) . Likewise, autonomic hyperactivity was shown to be involved in LUTS, whereas increased sympathetic activity may have a role in ED (37) . Electrophysiological recordings from pelvic nerves in patients with ED identified the changes in bulbocavernosus reflex (14, 44) , pudendo-urethral reflex (13) , and dorsal penile nerve cerebralevoked responses (14, 45) . This clinical evidence of nerve dysfunction in ED, especially when it is comorbid with LUTS, supports the occurrence of neural plasticity and participation of neurogenic mechanisms in the development of ED.
Among published animal data related to the changes in neural pathways underlying LUTS-ED dysfunction, the major findings included the changes in the autonomic nervous system. Animal models of neurogenic ED caused by peripheral nerve injury, detected axonal deterioration of the nerve fibers, and reduced nerve density in the CCSM, as well as altered peripheral release of neuropeptides and cytokines (8, 39, 46) . These models were characterized by long-lasting changes in neural pathways, extended recovery time, and partial reinnervation of the affected area (40) . They mostly mimic acute conditions such as nerve injury during radical prostatectomy in humans. The animal model of partial bladder outlet obstruction (PBOO) uses a different approach of continuous chronic compression of the bladder neck nerves, which mimics BPH development in patients with significantly enlarged prostate. Previous studies detected decreased innervation of the CCSM and diminished relaxation of CCSM strips in vitro in a rabbit model of PBOO (10) . Surgical obstruction of the bladder neck was also shown to trigger increased sympathetic activity contributing to the occurrence of both LUTS and ED (8) .
Recent investigations provide accumulating evidence for an important role of genitourinary sensory innervation for both erectile function and voiding reflex. Transmission of sensory inputs from the periphery to the central nervous system (CNS) is a critical step for psychological/physiological limbs of both erectogenic stimulation and control of micturition. Very lim-ited information is currently available about how BPH-associated compression of the bladder neck affects sensory nerves during the progression of prostate enlargement. Our previous studies characterized a phenomenon of afferent fiber convergence in the pelvis, which is involved in neural cross sensitization ("cross talk") among pelvic organs (32, 33) . One of the underlying mechanisms suggests the existence of peripheral axons, which split at some point, and, therefore, can coinnervate either different parts of the same organ or distinct pelvic organs (9, 11, 33) . No studies have been performed to date to test whether the same mechanism could occur with urinary bladder and penile sensory nerves, potentially contributing to LUTS-ED comorbidity. The objective of this work was to evaluate the effects of bladder neck nerve compression on sensory innervation of the CC and CCSM function using a rat model of PBOO. Specifically, we aimed to determine whether: 1) the urinary bladder and CCSM are innervated by the branches of the same sensory fibers; 2) PBOO, a primary cause of LUTS in males, can trigger temporary or permanent damage to sensory nerves innervating not only the urinary bladder but also the CC correlating with impaired sensation in ED; 3) PBOO affects the basal release of sensory neuropeptides in the pelvic organs; and 4) to identify potential molecular players involved in PBOO associated neural plasticity in the pelvis.
MATERIALS AND METHODS
Animals and experimental groups. Adult male Sprague-Dawley rats (N ϭ 50, 250 -300 g, Charles River Laboratories, Wilmington, MA) were used in this study. Animals were housed two per cage and maintained on a 12-h light/dark cycle with ad libitum access to water and food. Animals were divided into two experimental groups: 1) control group (sham surgery), and 2) experimental group with surgically induced partial bladder outlet obstruction (PBOO group). Animals from each group were used for in vivo and in vitro experiments 2 wk after the surgical procedures. All protocols were approved by the University of Pennsylvania Institutional Animal Care and Use Committee.
Animal model of partial bladder outlet obstruction. Surgical procedure to induce PBOO was performed as previously described (38) . Briefly, rats were anesthetized with 2% isoflurane and held on a warming pad inside the designated hood to minimize an investigator's exposure to the anesthetic. A low midline suprapubical laparotomy (1.5-2 cm in length) was performed under sterile conditions to gain access to the urethra. The urethra was carefully isolated from the surrounding prostate lobes. A sterile 21-g needle (0.81 outer diameter) was placed on the urethral surface, and a 3-0 silk suture was tied around both the urethra and the needle. As soon as the suture was secured, the needle was carefully removed, leaving the urethra partially obstructed. Sham surgery was also performed as described above except that suture around the urethra was left untied. Incisions were sutured in layers using a 4 -0 size chromic gut suture for the muscle layer and a 4 -0 nylon suture for the skin. Animals were allowed to recover on a warm blanket until they gained full consciousness and then were returned to their cages.
Surgical procedure for retrograde labeling of dorsal root ganglion neurons. In a separate set of rats, we performed double labeling with fluorescent retrograde tracers to test the hypothesis that some of the lumbosacral dorsal root ganglion (DRG) neurons may receive convergent afferent input from the penis and urinary bladder, and PBOO may affect the number of these cells. The sham or PBOO surgical procedures were combined with retrograde labeling of DRG neurons innervating the urinary bladder and penis. First, the surgical procedure to induce PBOO was completed, and then 1,1=-dioctadecyl-3,3,3=3=-tetramethylindocarbocyanine perchlorate (DiI; 1.5% wt/vol in methanol, red fluorescence; Molecular Probes, Eugene, OR) was injected close to the base of the penis at 6 -8 sites using a Hamilton syringe with a 26-gauge needle. Injections were placed in such a way to target predominantly the CCSM. This approach allowed the dye to stay within the organ and not being flushed away with the blood flow. Likewise, Fast Blue dye (FB, 1.5% wt/vol in water, blue fluorescence; Polysciences, Warrington, PA) was injected into the urinary bladder wall using the same approach. The total volume of each dye injected into organs was 10 -15 l. Adjacent pelvic organs were isolated with gauze to soak up any spills and prevent the labeling of adjacent structures during dye injections. Additionally, the needle was kept in place for 30 s after each injection and any leaked dye was immediately removed with a cotton swab. Incisions were sutured in layers under sterile conditions. Animals were allowed to recover on a warm blanket until they gained full consciousness and then were returned to their cages.
Isolation and analysis of L6-S2 dorsal root ganglia. Animals were euthanized at 2 wk after the surgeries, and L6, S1, and S2 DRG were isolated bilaterally along with the bladder and penis. Isolated structures were placed in HistoChoice tissue fixative solution (Amresco, Solon, OH) for 1-2 days. DRG were then transferred to 30% sucrose for cryoprotection, whereas bladder and penile tissues were embedded in paraffin for histological analysis of the injection cites. DRG were placed in optimal cutting temperature (OCT) compound (Sakura Tissue Teck, Torrance, CA) and rapidly frozen on dry ice. Frozen ganglia were sectioned on a cryotome at 10-m increments, and every fifth section was mounted onto slides. This approach allowed minimization of double counting of labeled neurons in adjacent sections as an average diameter of a DRG neuron lies within 20 -50 m. Sections were mounted in Vectashild (Vector Laboratories, Burlingame, CA) and visualized using a Nikon Eclipse Ti inverted microscope (Nikon, Lewisville, TX) connected to the Nikon Digital Sight Ri1 camera (Nikon). Images were acquired with MetaMorph version 6.2 software (Universal Imaging, Downingtown, PA). Quantitative analysis of the photomicrographic images was carried out by using Adobe Photoshop software (Adobe Systems, San Jose, CA). Because of the large total number of neurons (labeled and unlabeled), only DiI-labeled (CC afferent input), FB-labeled (urinary bladder afferents) and dual-labeled (convergent input) neurons were counted. Double-labeled neurons were identified by the presence of both red and blue fluorescence. The percentage of dual-labeled neurons was determined as a ratio of the sum of DiI and FB single-labeled neurons. Only cells with a clear nucleus and specific neuronal morphology were considered to be neurons.
Isolation of rat corpus cavernosum smooth muscle. Two weeks after the surgeries, rats were euthanized with overdose of pentobarbital sodium (120 mg/kg). The grossly dissected bladder-penis organ preparation was placed in cold oxygenated Tyrode buffer composed of (in mM) 124.9 NaCl, 2.5 KCl, 23.8 NaHCO 3, 0.5 MgCl2·6H2O, 0.4 NaH2PO4·H2O, 1.8 CaCl2, and 5.5 glucose. Care was taken to remove overlying skeletal muscle without damaging the underlying tunica albuginea containing the corpus cavernosum. The corpus cavernosum muscle strips were dissected free of the tunica bilaterally and placed either directly in an organ bath containing warm (37 C) Tyrode buffer equilibrated with 95% O2-5% CO2 for physiological studies (one set of animals) or immediately snap frozen in liquid nitrogen for subsequent mRNA and protein analyses (another set of animals).
In vitro measurements of CCSM contractility. For in vitro recordings of CCSM contractility, isolated CCSM strips were suspended from L-shaped hooks in 15-ml organ bath chambers. The chambers were filled with Tyrode buffer (in mM): 125 NaCl, 2.7 KCl, 23.8 NaHCO3, 0.5 MgCl2·6H2O, 0.4 NaH2PO4·H2O, 1.8 CaCl2, and 5.5 dextrose, maintained at 37°C, and perfused continuously with a mixture of 95% O2 and 5% CO2. After a 1-h equilibration, the length of optimal force development (Lo) was determined by increasing the length of each strip by 1-mm increments until a maximal contractile force to 125 mM KCl stimulation was achieved. The muscle was kept at Lo in Tyrode buffer for 30 min to allow stabilization at the resting level. The tissues were washed three times (10 min each) with Tyrode buffer before the application of ␣-adrenoreceptor agonist L-phenylephrine (Phe, 10 M) to trigger CCSM contractions followed by application of sodium nitroprusside (SNP, 10 M) to induce muscle relaxation. Contraction parameters were measured using PowerLab Lab-Chart version 7.1.2 software (ADinstruments, Colorado Springs, CO). The raw traces were analyzed manually and then exported into SigmaPlot 11.2 Software (Systat Software, San Jose, CA).
Protein extraction from CCSM and bladder tissues. Frozen bladder and CCSM samples isolated from sham and PBOO rats were homogenized using PowerGen 500 homogenizer (Fisher Scientific, Rockford, IL) in ice-cold lysis buffer containing 25% glycerol, 62.5 mM Tris·HCl, 1ϫ protease inhibitors (Roche, Complete mini), and phosphatase inhibitors (Roche, PhosSTOP). 10% SDS was added to the samples, vortexed, and boiled for 4 min. The extracts were centrifuged at 10,000 rpm for 15 min at 4°C, and supernatants with the total protein were collected. Protein concentration in each sample was detected using BCA protein assay kit (Thermo Fisher Scientific, Rockford, IL). Bovine serum albumin (BSA) was used to generate the standard curve. Each protein sample was diluted 1:20 with 1% SDS. All standards and samples were run in duplicate. The absorbance was measured at 562 nm on the Synergy 2 Multi-Detection Microplate Reader (BioTek Instruments, Winooski, VT) and data analysis was performed using Gen5 Microplate Data Collection & Analysis Software (BioTek Instruments).
Western blotting. Equal amounts of protein (20 g per lane, N ϭ 4 per group) were separated on 4 -15% SDS-polyacrylamide gels and transferred to a nitrocellulose membrane. After being blocked with Odyssey blocking buffer for 45 min at room temperature, the membranes were incubated overnight at 4°C with primary antibodies, including rabbit anti-neuronal nitric oxide synthase (nNOS, 1:1,000, cat. no. 4236, Cell Signaling Technology, Danvers, MA), anti-endothelial NOS (eNOS, 1:1,000, cat. no. 9586, Cell Signaling Technology), anti-protein kinase G-1 (PKG-1, 1:1,000, cat. no. 3248, Cell Signaling Technology), and mouse anti-␣-actin (sc-17829, Santa Cruz Biotechnology, Santa Cruz, CA, 1:200). The membranes were washed and incubated with secondary horseradish peroxidase-linked antirabbit antibody (1:5,000, cat. no. 16284, Abcam) or goat anti-mouse IgG-Cy3(1:2,500, GE Healthcare, PA43009) for 1 h at room temperature. Target proteins were detected using an enhanced chemiluminescence kit (cat. no. RPN2108, Amersham Life Sciences, Arlington Heights, IL), followed by scanning on a Fujifilm Image Reader LAS-3000 (Fujifilm, Valhalla, NY). The amount of protein in a band was determined by Optical Density scanning using Multi Gauge V 3.0 software (Fujifilm).
Quantification of substance P and calcitonin gene-related peptide content in the CCSM and urinary bladder. The levels of substance P (SP) in CCSM and urinary bladder tissues were measured using a rat substance P ELISA kit (MD Biosciences, St. Paul, MN) according to the manufacturer's instructions. Each sample and standards were run in duplicate. The concentration of total protein was 400 g/ml for SP assay. Briefly, a 96-well microplate was loaded with 25 l of primary antibody specific for rat SP. Fifty microliters of each sample and 50 l of the standard SP dilutions (as a control) were mixed in the assigned wells followed by the addition of biotinylated SP into each well except the blank. The plate was incubated for 2 h at room temperature and then washed six times with provided in the kit wash buffer. Subsequently, 100 l of biotinylated anti-SP antibody solution was added, incubated for 1 h, and then washed four times. A 100-l solution of streptavidin-horseradish peroxidase conjugate was added to each well except chromogen blank, incubated for 1 h, and washed again. After that, 100 l of substrate solution provided in the kit were added to each well, and the plate was incubated for 1 h at room temperature. The reaction was stopped with 2 N HCl, and the optical density values were read at 450 nm using a Biotek Synergy 2 plate reader (BioTek Instruments, Winooski, VT).
Calcitonin gene-related peptide (CGRP) levels were measured using CGRP enzyme immunoassay (EIA) kit for rats (ALPCO Diagnostic, Salem, NH) according to the manufacturer's instructions. The total protein concentration from each sample for CGRP assay was 200 g/ml. Briefly, a 96-well microplate was coated with 100 l of antibody specific for rat CGRP mixed with 100 l of EIA buffer provided in the kit plus 100 l of standard and sample aliquots. Plate was incubated for 16 -20 h at room temperature followed by the aspiration of the samples and washing them three times with wash buffer. Subsequently, 200 l of Ellman's reagent was added to each well, incubated for 30 -60 min in the dark, and then read between 405 and 414 nm using a Biotek Synergy 2 plate reader (BioTek Instruments). The protein concentrations of both SP and CGRP were statistically analyzed using two-way repeated measures ANOVA followed by comparisons between control and experimental groups using Bonferroni's method (Systat Software, San Jose, CA).
Statistical analysis. All data are expressed as the means Ϯ SE. Statistical significance between the groups was assessed by two-way repeated measures ANOVA followed by Bonferroni's posttest when appropriate (Systat Software, San Jose, CA). Difference between the groups and treatments was considered statistically significant at P Յ 0.05.
RESULTS
Histological and morphological evaluation of the CC and urinary bladder in a rat model of PBOO. Animals from both sham and PBOO groups were euthanized 2 wk after the surgery. After perfusion with paraformaldehyde, each bladderpenis organ preparation was carefully dissected from overlying skeletal muscle and connective tissues. First, specimens were screened for dye injection sites to confirm that the dyes did not cross leak after the surgery was completed. Figure 1A shows one of the bladder-penis organ preparations isolated from an animal in PBOO group. The penis presents with the red coloring predominantly in the lower half of the organ, and the urinary bladder has visible yellow spots of injected FB, which has blue color under fluorescent microscope. As seen in the figure, the silk suture at the base of the urinary bladder and large volume of residual urine confirm that the bladder neck was partially obstructed in this animal. After the initial evaluation was completed, the bladder was cut off and weighed, and a section with the most abundant dye spots was embedded in paraffin for histological evaluation. A section of the penis with the dye in the wall was also saved the same way as described for the urinary bladder. Histological evaluation of longitudinal sections of the penis showed that most of the dye was located within the CC muscle layer (Fig. 1B) . The FB spots were predominantly detected in the muscle bundles of the detrusor in rats from both sham and PBOO groups (Fig. 1C) . No overlap in dye labeling was observed in bladder-penis organ preparations isolated from rats in control and experimental groups. Additionally, a significant increase in bladder mass was detected in PBOO group compared with sham control (N ϭ 7 for both groups): the average bladder weight was 123 Ϯ 7.8 mg in sham-operated rats and 286.5 Ϯ 17.1 mg in animals with PBOO (132% increase, P Յ 0.01, Fig. 1D ).
Partial obstruction of the bladder neck affects sensory innervation of the corpus cavernosum. Single DiI or FB-labeled neurons were identified in L6-S2 sectioned ganglia. Figure 2 shows an example of S1 ganglion cross section isolated from control (Fig. 2, top) and PBOO (Fig. 2, bottom) animals. Sensory neurons receiving input from the urinary bladder were identified by blue fluorescence and neurons innervating the CC were labeled in red. Merged images show a few neurons in pink color (depicted by arrows), which contain both blue and red dyes, suggesting that they received the tracers from both organs. Double-labeled (from here on referred to as convergent) cells were identified in all analyzed ganglia. Because of a large total number of neurons (labeled and unlabeled), only DiI-labeled (CC projecting), FB-labeled (bladder projecting), and dual-labeled (convergent input) neurons were counted and statistically analyzed. The percentage of dual-labeled neurons was determined as a ratio of the sum of DiI and FB singlelabeled neurons. Analysis of retrograde-labeled sensory neurons is shown in Fig. 3 (Fig. 3B) . Additionally, the number of convergent sensory neurons was reduced by PBOO down to 2-3% in sacral DRG (Fig. 3C) . These results suggest that PBOO triggers neural plasticity in sensory afferents supplying the CC, thereby, affecting the sensory component of ED development. Reduced number of convergent sensory neurons innervating the urinary bladder and CC may contribute to a neurogenic component of comorbidity between the LUTS and ED. Changes in CCSM contractility and relaxation induced by PBOO. Strips of CCSM isolated from sham and PBOO rats (ϳ25 mg, Fig. 4A ) were longitudinally suspended in organ baths for contraction/relaxation experiments. The mean maximum force generated CCSM strips isolated from sham rats in response to 125 mM KCl was 4.9 Ϯ 0.9 g/g (N ϭ 4, n ϭ 7), whereas strips from PBOO group had a mean of 2.6 Ϯ 0.3 g/g, reflecting an ϳ47% decrease in maximum force (N ϭ 4, n ϭ 7, P Յ 0.02, Fig. 4B ). Diminished contractile response of CCSM to stimulation with Phe was also observed in the PBOO group reaching 2.8 Ϯ 0.3 g/g (n ϭ 7) compared with 4.3 Ϯ 0.5 g/g in sham rats (n ϭ 7, P ϭ 0.04, Fig. 4B ). In addition, precontracted with Phe strips of CCSM from PBOO rats were more difficult to relax by SNP compared with sham-operated animals (Fig. 4C) .
Modulation of NOS and PKG expression by PBOO in CCSM.
To identify molecular candidates involved in altered contractility and relaxation of the CCSM, we evaluated protein expression of both nNOS and eNOS, as well as PKG-1, an established modulator of NOS activity, in the CCSM (30) . Figure 5A shows the gels with protein bands from control (S1-S4) and PBOO (P1-P4) groups. Analysis of relative protein expression (Fig. 5B ) determined that obstruction of the bladder neck caused a significant decrease in nNOS expression in the PBOO group (by 50%, P Յ 0.05) compared with sham CCSM. In contrast, the expression of eNOS showed a trend of increased expression without reaching statistical significance. There was no change in PKG-1 expression between control and PBOO groups of rats (Fig. 5B) .
Obstruction of the bladder neck affects the release of sensory neuropeptides in the CC and urinary bladder. Since PBOO can affect both afferent and efferent nerve fibers, we sought to distinguish the effects on sensory nerves from the effects on efferent fibers. It is well established that sensory afferents release specific sensory neuropeptides in the viscera upon peripheral stimulation (23, 34) . We ran SP and CGRP ELISA assays for the proteins isolated from the urinary bladder and CCSM in both control and PBOO samples. These experiments established that the CC had higher level of SP content (2.01 Ϯ 0.23 ng/ml, N ϭ 5, n ϭ 10) compared with the urinary bladder (0.3 Ϯ 0.05 ng/ml, N ϭ 5, n ϭ 8, P Յ 0.001, Fig. 6A ) under normal physiological conditions. However, physiological concentration of CGRP was significantly higher in the urinary bladder reaching 120.6 Ϯ 37.2 pg/ml compared with 14.5 Ϯ 0.9 pg/ml in the CC (P ϭ 0.003, Fig. 6B ). PBOO diminished SP release from sensory terminals as evidenced by a fivefold downregulation of SP concentration in the CC (N ϭ 5, n ϭ 10, P Յ 0.001, Fig. 6A ) without significant changes in the obstructed bladder. Interestingly, concentration of CGRP was downregulated in the urinary bladder by PBOO without parallel changes in the CC; however, the decrease did not reach the level of statistical significance (Fig. 6B) . These results provide evidence that PBOO causes neural plasticity in afferent pathways associated with downregulation of neuropeptide content in the affected organs.
DISCUSSION
This study investigated the neural mechanisms of LUTS-ED comorbidity with focus on sensory innervation of the CC and urinary bladder using a rat model of PBOO. We provided direct evidence for the presence of convergent bladder-penis DRG neurons in lumbosacral sensory ganglia and established that the number of these neurons is decreased after partial obstruction of the bladder neck. Additional important findings included reduced relaxation of CCSM strips in response to NO donor, downregulation of neuronal NOS expression, and a decreased content of sensory neuropeptides in the CCSM of rats with PBOO. The results of our work provide additional support for a neurogenic component in ED development and suggest that PBOO induces neural plasticity in afferent pathways of the penis and urinary bladder, thereby, contributing to LUTS-ED comorbidity and impaired sensation during ED development.
Previous clinical studies suggested that neurogenic ED often results from surgical management of invasive bladder cancers and other low pelvic malignancies including colon and rectal cancers (3). The peripheral nervous system demonstrates limited intrinsic ability to recover after axonal damage due to pelvic surgery or trauma. While peripheral axons can regenerate and partially reinnervate a damaged organ, these changes do not guarantee the full recovery of a neurogenic function (39) . In this study, we tested the hypothesis that one of the mechanisms linking LUTS and ED involves impairment of sensory nerves supplying the urinary bladder and penis. Our group has previously shown that there is a network of sensory 
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-100 kDa Fig. 5 . Expression of neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS), and protein kinase G-1 (PKG-1) protein in sham-operated and PBOO rats. Total protein was extracted from the CC of four pairs of sham-operated and PBOO rats, and equal amounts of total extractable protein were then loaded onto a mini 12% SDS-polyacrylamide gel and analyzed as described in MATERIALS AND METHODS. A: images of the Western blot membranes probed with antibodies against eNOS, nNOS, and PKG-1. S1-S4, Sham-operated rats; P1-P4, rats with PBOO. B: relative protein expression normalized to the level of ␣-actin. Please note that the expression of nNOS was decreased in the CC from PBOO rats compared with the CC from sham group (N ϭ 4, P Յ 0.05), while the expression of eNOS and PKG-1 was not significantly altered. ␣-Actin was run as an internal control and was not significantly different between the groups. nerves that have dichotomized axons supplying adjacent pelvic structures (33) . These convergent afferents play a role in the development of cross sensitization among pelvic organs via neural pathways (4, 7, 32, 54) . The presence of sensory neurons receiving convergent afferent input from the pelvic viscera in animal models was previously shown for the lower gastrointestinal, urinary and reproductive organs (9, 11, 33) . The percentage of DRG neurons with multiple or dichotomizing axons usually lies within 3-10% (9, 11, 12, 33) , which correlates with the number of bladder-penis convergent cells observed in this study. Our results from retrograde tracing experiments in rats with PBOO also supported our suggestion that mild obstruction of the bladder neck nerves can be associated with impairment of sensory axons supplying both organs. Therefore, we provide additional evidence that PBOO, a primary cause of LUTS in males, induces damage to the nerve fibers innervating not only the bladder but also the CC contributing to a neurogenic development of ED. We emphasize that alterations in neural pathways triggered by PBOO are not suggested to be the primary cause for LUTS-ED comorbidity but rather play a modulatory role in addition to main mechanisms such as vascular changes, altered tone/contractility of CCSM, phosphodiesterase-dependent pathway (36, 42, 50, 59 ). Impairment of nerve and blood supply by obstruction of the bladder is associated with a number of changes in the contractility of visceral smooth muscle. The majority of the available reports investigated the effects of PBOO on the function of bladder detrusor and only few studies focused on the contractility of the CCSM. The exact mechanisms by which PBOO can trigger changes in CCSM contractility and relaxation remain unknown. In our rat model of PBOO, we observed a ϳ2.5-fold increase in bladder weight after 2 wk of obstruction. This correlates with the previous studies which established that denervation of the pelvic organs was associated with smooth muscle proliferation and thickening (16, 60) . Partial bladder outlet obstruction can result in either mild or severe obstruction depending on several factors such as the duration of obstruction (58) and diameter of the surgical ligation (51) . The inclusion of sham-operated animals in our study ruled out direct injury by trauma due to surgical intervention since a suture was also placed around the urethra of sham-operated rats, although without ligation. Thus constant compression of the nerves that travel through the bladder neck region to supply the CCSM was not present in sham-operated controls and may have contributed to the decreased sensory innervation in the CCSM in rats with PBOO. Despite the benefits of the surgical approach used in our study in a recapitulation of the events that take place in clinical PBOO, the acute nature of surgical intervention does not fully mimic the slow progression of BPH and/or development of ED observed in aging men. The major difficulty in studying the correlation between LUTS/BPH and ED is a limited number of experimental animal models combining prostate enlargement, bladder obstruction, and ED all at once. To test whether the impairment of sensory nerves depends on the method of PBOO induction, our findings should also be tested in additional animal models such as estrogen/testosterone-induced BOO (41) or in testosterone-supplemented spontaneously hypertensive rats (43) .
We determined that partial obstruction of the bladder neck led to a decreased contractility of CCSM upon stimulation with KCl or Phe. Other groups reported similar observations including diminished CCSM contractility under ischemic conditions resulted from occlusion of abdominal aorta in vivo (52). Lin et al. (29) observed a decrease in the contractile response of the CCSM to Phe in a rabbit model of PBOO, whereas another group detected the opposite effect (10) . Variability in contractility responses of the CCSM among the studies is likely associated with phasic molecular changes underlying adaptation of the CC muscle to new conditions induced by PBOO development. Other important contributing factors may include species differences, severity and duration of obstruction, degree of smooth muscle hypertrophy, and variability in methodological approaches. Despite the reported differences in contractile responses of the CCSM, all groups, including ours, detected a significant decrease in relaxation of CCSM strips isolated from PBOO animals (10, 22, 29) . Impairment of CCSM relaxation was suggested to be associated primarily with upregulation of Rho-kinase expression/activity and changes in NO/NOS signaling (59) . NO is a vasodilator regulating multiple physiological and pathophysiological processes, including host-defense response, neuronal communication, and vascular tone (18) . NO is released from nonadrenergic noncholinergic nerves and endothelial cells (26, 48) and relaxes CCSM through the activation of the sGC/cGMP/PKG signaling cascade (2) . PKG pathway is also involved in regulation of cardiac contractility, axon guidance, bone growth, smooth muscle relaxation, and erectile dysfunction (21, 30) . In Rosen (50) and McVary's (35) review papers, NO and NOSrelated dysfunctions are listed as one of the mechanisms underlying the link between LUTS and ED. However, the information about the effects of PBOO on NO/NOS pathway is still limited.
Since the focus of our study was on neural mechanisms, we aimed to further establish if a decrease in CCSM relaxation was associated with the changes in expression of nNOS-and/or PKG-related pathways. Our results confirmed a downregulation of nNOS in CCSM of animals with PBOO, whereas other signaling molecules such as eNOS and PKG-1 did not change significantly between sham-operated and PBOO rats. These data correlate with a report by Klotz et al. (26a) , which determined a significant decrease in nitrinergic innervation and nNOS in hyperplastic obstructive human prostates compared with normal nonobstructive ones (27) . An experimental model of rat PBOO showed a similar decrease of nNOS in the CCSM isolated from obstructed animals, which may contribute to ED during PBOO development (20) .
Partial obstruction of the bladder neck affects both afferent and efferent fibers coursing through the urethra. Therefore, we attempted to distinguish the effects of PBOO on sensory nerves from the effects on efferent fibers. It is well established that sensory afferents contain vasodilating neuropeptides, such as SP and CGRP, which are released from peripheral terminals upon sensory stimulation (23, 34) . CGRP and SP are the main neuropeptides released from the sensory fibers innervating pelvic organs (47, 55, 57) . Both of them are highly expressed in primary afferent neurons projecting to the urinary bladder, distal colon, and reproductive organs (11, 25) . Release of SP and CGRP from peripheral nerves is usually associated with development of arteriolar vasodilation. A number of important factors underlie the effects of neuropeptide release including content, transport to nerve terminals (peripheral), rate of peptide metabolism, and positive/negative feedback on synthesis and/or release (31) . At the subcellular level, CGRP is often costored with tachykinins in large dense cored vesicles in trigeminal and DRG neurons (19) . However, SP does not have the storage capacity in peripheral terminals, and the continual activation may be evident as a partially depleted terminal. Unlike SP, CGRP was found to be more metabolically stable than the coreleased tachykinins (28) . Our results showed that PBOO caused some impairment to sensory nerves associated with fivefold downregulation of SP in the CC without significant changes in the obstructed bladder. Interestingly, concentration of CGRP was downregulated by PBOO in the urinary bladder without parallel changes in the CC, however, without reaching the level of statistical significance. Differential effects of PBOO on SP and CGRP basal release could be explained, in part, by various basal concentrations of these neuropeptides in the pelvic organs under normal physiological conditions. Thus basal level of SP in the CC was sixfold higher compared with the urinary bladder, whereas the concentration of CGRP was eightfold higher in the urinary bladder than in the CC. Together, these data suggest that PBOO causes neural plasticity in afferent pathways associated with downregulation of neuropeptide release from peripheral sensory terminals.
Perspectives and Significance
We present the novel findings of molecular and functional changes in the nerve supply of the CCSM associated with PBOO. PBOO leads to alterations in bladder neck sensory innervation followed by decreased CCSM relaxation, downregulation of nNOS expression in the CC, and reduced basal release of vasodilatory neuropeptides from peripheral sensory terminals. Our results provide evidence that altered neural plasticity induced by PBOO may contribute to the development of ED causing subsequent changes in the contraction/relaxation mechanisms of CCSM. In light of the expansive epidemiological presence and significant LUTS-ED comorbidity, further basic and translational studies to clarify the mechanistic link between these two pathologies are warranted.
